[155 Pages Report] The global 3D cell culture market size is projected to reach USD 1,846 million in 2024 from USD 892 million in 2019, at a CAGR of 15.7%. The growth of this market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period.
Based on application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. The cancer & stem cell research segment accounted for the largest share of the market in 2018 and is expected to register the highest CAGR during the forecast period. The increasing prevalence of cancer and significant funding for cancer research are major factors driving the growth of this application segment.
Based on product, the market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest share of the market in 2018. The advantages of scaffolds in 3D cell culture, such as structural rigidity and the availability of attachment points, have greatly driven the preference for scaffold-based 3D cell cultures and ensured the large share of this segment.
Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the market in 2018. The presence of a large number of pharmaceutical & biotechnology companies, an increase in R&D spending in these companies, and the growing preference for alternative testing models over animal techniques are the key market drivers in this end-user segment.
In 2018, North America commanded the largest share of the market due to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry. However, the market in Europe is expected to grow at the highest CAGR during the forecast period. The growth of the market in Europe is attributed to the growth of its pharmaceutical and biotechnology industry, recent commercialization of microfluidics-based products, the increasing presence of major market players, and a large number of research activities conducted in the region.
Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), H΅rel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), and PromoCell (Germany).
Thermo Fisher Scientific is the leading player in the 3D cell culture market. The leading position of the company can be attributed to its strong brand image and robust product portfolio. The company has a strong foothold in the market with its established brandAlgiMatrix. To maintain its leading position in the market, the company focuses on R&D activities and product launches. The company invested USD 967 million, USD 887 million, and USD 754 million in R&D activities in 2018, 2017, and 2016, respectively. It also adopts organic and inorganic growth strategies such as acquisitions and expansions in order to maintain its position in this market. For instance, in October 2018, Thermo Fisher Scientific acquired the Advanced Bioprocessing business of BD (US) to enhance its presence in the cell culture media products market.
Report Metric |
Details |
Market size available for years |
20172024 |
Base year considered |
2018 |
Forecast period |
20192024 |
Forecast units |
Value (USD) |
Segments covered |
Product, application, end user, and region |
Geographies covered |
North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (Japan, China, India, and Rest of Asia Pacific), and the Rest of the World (RoW) |
Companies covered |
Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), H΅rel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), and PromoCell (Germany) |
The research report categorizes the market into the following segments and subsegments:
Which is the leading products of 3D cell culture?
Based on product, the market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest share of the market in 2018. The advantages of scaffolds in 3D cell culture, such as structural rigidity and the availability of attachment points, have greatly driven the preference for scaffold-based 3D cell cultures and ensured the large share of this segment.
Which is the leading end user for 3D cell culture?
Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the market in 2018. The presence of a large number of pharmaceutical & biotechnology companies, an increase in R&D spending in these companies, and the growing preference for alternative testing models over animal techniques are the key market drivers in this end-user segment.
Which is the leading application of 3D cell culture?
Based on application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. The cancer & stem cell research segment accounted for the largest share of the market in 2018 and is expected to register the highest CAGR during the forecast period. The increasing prevalence of cancer and significant funding for cancer research are major factors driving the growth of this application segment.
Who are the key players operating in the 3D cell culture market?
Prominent players in 3D cell culture market include Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), H΅rel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), and PromoCell (Germany).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 20)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.3.1 Revenue Mapping-Based Market Estimation
2.4 Market Data Estimation and Triangulation
2.5 Assumptions of the Study
3 Executive Summary (Page No. - 30)
4 Premium Insights (Page No. - 33)
4.1 3D Cell Culture Market Overview
4.2 Scaffold-Based 3D Cell Cultures Market, By Type, 20192024 (USD Million)
4.3 3D Cell Culture Market Share, By End User & Region (2018)
4.4 3D Cell Culture Market: Geographic Growth Opportunities
5 Market Overview (Page No. - 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Focus on Developing Alternatives to Animal Testing
5.2.1.2 Growing Focus on Personalized Medicine
5.2.1.3 Increasing Incidence of Chronic Diseases
5.2.1.4 Availability of Funding for Research
5.2.2 Restraints
5.2.2.1 Lack of Infrastructure for 3D Cell-Based Research
5.2.2.2 High Cost of Cell Biology Research
5.2.3 Opportunities
5.2.3.1 Emergence of Microfluidics-Based 3D Cell Culture
5.2.3.2 Emerging Economies
5.2.3.3 Regenerative MedicineAn Alternative to Organ Transplantation
5.2.4 Challenges
5.2.4.1 Lack of Consistency in 3D Cell Culture Products
6 3D Cell Culture Market, By Product (Page No. - 43)
6.1 Introduction
6.2 Scaffold-Based 3D Cell Cultures
6.2.1 Hydrogels/ECM Analogs
6.2.1.1 Hydrogels/ECM Analogs Dominate the Scaffold-Based 3D Cell Cultures Market
6.2.2 Solid Scaffolds
6.2.2.1 Solid Scaffolds are Widely Adopted in Regenerative Medicine and Preclinical in Vitro Testing
6.2.3 Micropatterned Surfaces
6.2.3.1 Micropatterned Surfaces Enhance the Expression of Enzymes Levels and Drug Reactivity
6.3 Scaffold-Free 3D Cell Cultures
6.3.1 Low Attachment Plates
6.3.1.1 Low Attachment Plates are Expected to Grow at the Highest Rate in the Scaffold-Free 3D Cell Cultures Market
6.3.2 Hanging Drop Plates
6.3.2.1 Hanging Drop Plates are Widely Used in Stem Cell Differentiation and Cytotoxicity Research
6.3.3 3D Bioreactors
6.3.3.1 3D Bioreactors are Commonly Used in the Mass Production of Cells
6.3.4 3D Petri Dishes
6.3.4.1 Europe Will Witness the Highest Growth in the 3D Petri Dishes Market
6.4 Microfluidics-Based 3D Cell Cultures
6.4.1 Microfluidics-Based 3D Cell Cultures Will Grow at the Highest Rate in the 3D Cell Culture Market
6.5 Magnetic & Bioprinted 3D Cell Cultures
6.5.1 3D Cell Culture Can Be Formed Without Media in Magnetic Levitation
7 3D Cell Culture Market, By Application (Page No. - 64)
7.1 Introduction
7.2 Cancer & Stem Cell Research
7.2.1 Rising Prevalence of Cancer is A Key Factor Driving the Growth of This Segment
7.3 Drug Discovery & Toxicology Testing
7.3.1 Increasing Adoption of Personalized Medicines to Support Market Growth
7.4 Tissue Engineering & Regenerative Medicine
7.4.1 Europe is Expected to Register the Highest Growth in the Tissue Engineering & Regenerative Medicine Market
8 3D Cell Culture Market, By End User (Page No. - 71)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Pharmaceutical & Biotechnology Companies are the Largest End Users of 3D Cell Culture
8.3 Research Institutes
8.3.1 Increasing Government Funding for Research & High Prevalence of Cancer are Driving Market Growth
8.4 Cosmetics Industry
8.4.1 Focus on Developing Alternatives to Animal Testing is A Key Factor Driving Market Growth
8.5 Other End Users
9 3D Cell Culture Market, By Region (Page No. - 80)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Advancements in the Field of Regenerative Medicine to Drive Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Investments By Various Key Players and Growing Funding From Government Organizations to Drive the Market
9.3.2 UK
9.3.2.1 Growth in the Life Sciences Industry to Drive Market Growth in the UK
9.3.3 France
9.3.3.1 Growth in the Biotechnology Industry to Drive Market Growth in France
9.3.4 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Japan to Dominate the Asia Pacific Market
9.4.2 China
9.4.2.1 Government Support & Strategic Initiatives By Key Players to Strengthen the Biotechnology Sector in China
9.4.3 India
9.4.3.1 Growth in the Life Sciences Industry to Support Market Growth in India
9.4.4 RoAPAC
9.5 Rest of the World
10 Competitive Landscape (Page No. - 115)
10.1 Overview
10.2 Market Shares Analysis, 2018
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Dynamic Differentiators
10.3.3 Innovators
10.3.4 Emerging Companies
10.4 Competitive Situation and Trends
10.4.1 Product Launches & Upgrades
10.4.2 Expansions
10.4.3 Acquisitions
10.4.4 Partnerships, Agreements, Alliances, and Collaborations
10.4.5 Other Strategies
11 Company Profiles (Page No. - 121)
(Business Overview, Products Offered, Recent Developments & MnM View)*
11.1 Thermo Fisher Scientific
11.2 Corning Incorporated
11.3 Merck KGaA
11.4 Lonza Group
11.5 Reprocell
11.6 3D Biotek LLC
11.7 Emulate, Inc.
11.8 CN Bio Innovations Limited
11.9 Hamilton Company
11.10 Insphero AG
11.11 Kirkstall, LTD.
11.12 Mimetas BV
11.13 Tissuse GmbH
11.14 Synthecon Incorporated
11.15 QGEL SA
*Details on Business Overview, Products Offered, Recent Developments & MnM View Might Not Be Captured in Case of Unlisted Companies.
11.16 Other Key Players
11.16.1 Greiner Bio-One International GmbH
11.16.2 Promocell GmbH
11.16.3 Advanced Biomatrix, Inc.
11.16.4 H΅rel Corporation
11.16.5 Synvivo, Inc.
12 Appendix (Page No. - 150)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables (156 Tables)
Table 1 Growth in the Number of Personalized Medicines
Table 2 Prevalence of Diabetes, By Region, 2000 vs 2030
Table 3 Incidence of Cancer, By Type, 2018 vs 2040
Table 4 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 5 Scaffold-Based 3D Cell Cultures Market, By Product, 20172024 (USD Million)
Table 6 Scaffold-Based 3D Cell Cultures Market, By Region, 20172024 (USD Million)
Table 7 North America: Scaffold-Based 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 8 Europe: Scaffold-Based 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 9 Asia Pacific: Scaffold-Based 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 10 Hydrogels/ECM Analogs Market, By Region, 20172024 (USD Million)
Table 11 North America: Hydrogels/ECM Analogs Market, By Country, 20172024 (USD Million)
Table 12 Europe: Hydrogels/ECM Analogs Market, By Country, 20172024 (USD Million)
Table 13 Asia Pacific: Hydrogels/ECM Analogs Market, By Country, 20172024 (USD Million)
Table 14 Solid Scaffolds Market, By Region, 20172024 (USD Million)
Table 15 North America: Solid Scaffolds Market, By Country, 20172024 (USD Million)
Table 16 Europe: Solid Scaffolds Market, By Country, 20172024 (USD Million)
Table 17 Asia Pacific: Solid Scaffolds Market, By Country, 20172024 (USD Million)
Table 18 Micropatterned Surfaces Market, By Region, 20172024 (USD Million)
Table 19 North America: Micropatterned Surfaces Market, By Country, 20172024 (USD Million)
Table 20 Europe: Micropatterned Surfaces Market, By Country, 20172024 (USD Million)
Table 21 Asia Pacific: Micropatterned Surfaces Market, By Country, 20172024 (USD Million)
Table 22 Scaffold-Free 3D Cell Cultures Market, By Product, 20172024 (USD Million)
Table 23 Scaffold-Free 3D Cell Cultures Market, By Region, 20172024 (USD Million)
Table 24 North America: Scaffold-Free 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 25 Europe: Scaffold-Free 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 26 Asia Pacific: Scaffold-Free 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 27 Low Attachment Plates Market, By Region, 20172024 (USD Million)
Table 28 North America: Low Attachment Plates Market, By Country, 20172024 (USD Million)
Table 29 Europe: Low Attachment Plates Market, By Country, 20172024 (USD Million)
Table 30 Asia Pacific: Low Attachment Plates Market, By Country, 20172024 (USD Million)
Table 31 Hanging Drop Plates Market, By Region, 20172024 (USD Million)
Table 32 North America: Hanging Drop Plates Market, By Country, 20172024 (USD Million)
Table 33 Europe: Hanging Drop Plates Market, By Country, 20172024 (USD Million)
Table 34 Asia Pacific: Hanging Drop Plates Market, By Country, 20172024 (USD Million)
Table 35 3D Bioreactors Market, By Region, 20172024 (USD Million)
Table 36 North America: 3D Bioreactors Market, By Country, 20172024 (USD Million)
Table 37 Europe: 3D Bioreactors Market, By Country, 20172024 (USD Million)
Table 38 Asia Pacific: 3D Bioreactors Market, By Country, 20172024 (USD Million)
Table 39 3D Petri Dishes Market, By Region, 20172024 (USD Million)
Table 40 North America: 3D Petri Dishes Market, By Country, 20172024 (USD Million)
Table 41 Europe: 3D Petri Dishes Market, By Country, 20172024 (USD Million)
Table 42 Asia Pacific: 3D Petri Dishes Market, By Country, 20172024 (USD Million)
Table 43 Microfluidics-Based 3D Cell Culture Market, By Region, 20172024 (USD Million)
Table 44 North America: Microfluidics-Based 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 45 Europe: Microfluidics-Based 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 46 Asia Pacific: Microfluidics-Based 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 47 Magnetic & Bioprinted 3D Cell Cultures Market, By Region, 20172024 (USD Million)
Table 48 North America: Magnetic & Bioprinted 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 49 Europe: Magnetic & Bioprinted 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 50 Asia Pacific: Magnetic & Bioprinted 3D Cell Cultures Market, By Country, 20172024 (USD Million)
Table 51 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 52 3D Cell Culture Market for Cancer & Stem Cell Research, By Region, 20172024 (USD Million)
Table 53 North America: 3D Cell Culture Market for Cancer & Stem Cell Research, By Country, 20172024 (USD Million)
Table 54 Europe: 3D Cell Culture Market for Cancer & Stem Cell Research, By Country, 20172024 (USD Million)
Table 55 Asia Pacific: 3D Cell Culture Market for Cancer & Stem Cell Research, By Country, 20172024 (USD Million)
Table 56 3D Cell Culture Market for Drug Discovery & Toxicology Testing, By Region, 20172024 (USD Million)
Table 57 North America: 3D Cell Culture Market for Drug Discovery & Toxicology Testing, By Country, 20172024 (USD Million)
Table 58 Europe: 3D Cell Culture Market for Drug Discovery & Toxicology Testing, By Country, 20172024 (USD Million)
Table 59 Asia Pacific: 3D Cell Culture Market for Drug Discovery & Toxicology Testing, By Country, 20172024 (USD Million)
Table 60 3D Cell Culture Market for Tissue Engineering & Regenerative Medicine, By Region, 20172024 (USD Million)
Table 61 North America: 3D Cell Culture Market for Tissue Engineering & Regenerative Medicine, By Country, 20172024 (USD Million)
Table 62 Europe: 3D Cell Culture Market for Tissue Engineering & Regenerative Medicine, By Country, 20172024 (USD Million)
Table 63 Asia Pacific: 3D Cell Culture Market for Tissue Engineering & Regenerative Medicine, By Country, 20172024 (USD Million)
Table 64 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 65 3D Cell Culture Market for Pharmaceutical & Biotechnology Companies, By Region, 20172024 (USD Million)
Table 66 North America: 3D Cell Culture Market for Pharmaceutical & Biotechnology Companies, By Country, 20172024 (USD Million)
Table 67 Europe: 3D Cell Culture Market for Pharmaceutical & Biotechnology Companies, By Country, 20172024 (USD Million)
Table 68 Asia Pacific: 3D Cell Culture Market for Pharmaceutical & Biotechnology Companies, By Country, 20172024 (USD Million)
Table 69 3D Cell Culture Market for Research Institutes, By Region, 20172024 (USD Million)
Table 70 North America: 3D Cell Culture Market for Research Institutes, By Country, 20172024 (USD Million)
Table 71 Europe: 3D Cell Culture Market for Research Institutes, By Country, 20172024 (USD Million)
Table 72 Asia Pacific: 3D Cell Culture Market for Research Institutes, By Country, 20172024 (USD Million)
Table 73 3D Cell Culture Market for the Cosmetics Industry, By Region, 20172024 (USD Million)
Table 74 North America: 3D Cell Culture Market for the Cosmetics Industry, By Country, 20172024 (USD Million)
Table 75 Europe: 3D Cell Culture Market for the Cosmetics Industry, By Country, 20172024 (USD Million)
Table 76 Asia Pacific: 3D Cell Culture Market for the Cosmetics Industry, By Country, 20172024 (USD Million)
Table 77 3D Cell Culture Market for Other End Users, By Region, 20172024 (USD Million)
Table 78 North America: 3D Cell Culture Market for Other End Users, By Country, 20172024 (USD Million)
Table 79 Europe: 3D Cell Culture Market for Other End Users, By Country, 20172024 (USD Million)
Table 80 Asia Pacific: 3D Cell Culture Market for Other End Users, By Country, 20172024 (USD Million)
Table 81 3D Cell Culture Market, By Region, 20172024 (USD Million)
Table 82 North America: 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 83 North America: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 84 North America: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 85 North America: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 86 North America: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 87 North America: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 88 US: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 89 US: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 90 US: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 91 US: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 92 US: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 93 Canada: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 94 Canada: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 95 Canada: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 96 Canada: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 97 Canada: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 98 Europe: 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 99 Europe: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 100 Europe: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 101 Europe: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 102 Europe: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 103 Europe: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 104 Germany: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 105 Germany: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 106 Germany: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 107 Germany: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 108 Germany: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 109 UK: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 110 UK: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 111 UK: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 112 UK: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 113 UK: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 114 France: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 115 France: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 116 France: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 117 France: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 118 France: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 119 RoE: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 120 RoE: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 121 RoE: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 122 RoE: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 123 RoE: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 124 APAC: 3D Cell Culture Market, By Country, 20172024 (USD Million)
Table 125 APAC: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 126 APAC: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 127 APAC: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 128 APAC: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 129 APAC: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 130 Japan: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 131 Japan: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 132 Japan: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 133 Japan: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 134 Japan: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 135 China: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 136 China: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 137 China: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 138 China: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 139 China: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 140 India: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 141 India: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 142 India: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 143 India: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 144 India: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 145 RoAPAC: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 146 RoAPAC: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 147 RoAPAC: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 148 RoAPAC: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 149 RoAPAC: 3D Cell Culture Market, By End User, 20172024 (USD Million).
Table 150 RoW: 3D Cell Culture Market, By Product, 20172024 (USD Million)
Table 151 RoW: Scaffold-Based 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 152 RoW: Scaffold-Free 3D Cell Cultures Market, By Type, 20172024 (USD Million)
Table 153 RoW: 3D Cell Culture Market, By Application, 20172024 (USD Million)
Table 154 RoW: 3D Cell Culture Market, By End User, 20172024 (USD Million)
Table 155 Exchange Rates (Utilized for Conversion of Eur to USD)
Table 156 Exchange Rates (Utilized for Conversion of Chf to USD)
List of Figures (25 Figures)
Figure 1 Research Methodology Steps: 3D Cell Culture Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall 3D Cell Culture Market
Figure 6 Data Triangulation Methodology
Figure 7 3D Cell Culture Market, By Product, 2019 vs 2024 (USD Million)
Figure 8 3D Cell Culture Market, By Application, 2019 vs 2014 (USD Million)
Figure 9 3D Cell Culture Market, By End User, 20192024 (USD Million)
Figure 10 Geographical Snapshot of the 3D Cell Culture Market
Figure 11 Increasing Focus on Developing Alternatives to Animal Testing is A Major Factor Driving the Adoption of 3D Cell Culture Solutions
Figure 12 Hydrogels/ECM Analogs are Expected to Dominate the Market During the Forecast Period
Figure 13 Pharmaceutical & Biotechnology Companies Accounted for the Largest Share of the Market in 2018
Figure 14 Europe is Expected to Grow at the Highest Rate During the Forecast Period
Figure 15 3D Cell Culture Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 North America: 3D Cell Culture Market Snapshot
Figure 17 Europe: 3D Cell Culture Market Snapshot
Figure 18 Key Players Adopted Organic as Well as Inorganic Growth Strategies
Figure 19 Market Evolution Framework
Figure 20 3D Cell Culture Market Shares Analysis, By Key Player, 2018
Figure 21 Competitive Leadership Mapping
Figure 22 Thermo Fisher Scientific: Company Snapshot
Figure 23 Corning Incorporated: Company Snapshot
Figure 24 Merck KGaA: Company Snapshot
Figure 25 Lonza Group: Company Snapshot
The study involved four major activities in estimating the current size of the global 3D cell culture market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global market. Secondary sources include directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the global 3D cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs.
The following customization options are available for this report.
Benchmarking the rapid strategy shifts of the Top 100 companies in the 3D Cell Culture Market
Request For Special Pricing
Growth opportunities and latent adjacency in 3D Cell Culture Market